Oral Oncology
Volume 39, Issue 3 , Pages 248-258 , April 2003

Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis

  • C Leethanakul

      Affiliations

    • Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, 30 Convent Drive, Building 30, Room 212, Bethesda, MD 20892-4340, USA
    • Present address: Faculty of Dentistry, Prince of Songkla University, Hadd Yai, Songkhla 90112, Thailand.
  • ,
  • V Knezevic

      Affiliations

    • Cancer Genome Anatomy Project, Office of the Director, National Cancer Institute, National Institutes of Health, Advanced Technology Center, 8717 Grovemont Circle, 134F, Gaithersburg, MD 20877, USA
    • Present address: 20/20 GeneSystems, Inc., 9700 Great Seneca Highway, Rockville, MD 20850, USA.
  • ,
  • V Patel

      Affiliations

    • Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, 30 Convent Drive, Building 30, Room 212, Bethesda, MD 20892-4340, USA
  • ,
  • P Amornphimoltham

      Affiliations

    • Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, 30 Convent Drive, Building 30, Room 212, Bethesda, MD 20892-4340, USA
  • ,
  • J Gillespie

      Affiliations

    • Science Applications International Corporation, National Cancer Institute, Bethesda, MD 20892, USA
  • ,
  • E.J Shillitoe

      Affiliations

    • Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
  • ,
  • P Emko

      Affiliations

    • Department of Otolaryngology and Communication Sciences, SUNY Upstate Medical University, Syracuse, NY 13210, USA
  • ,
  • M.H Park

      Affiliations

    • Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, 30 Convent Drive, Building 30, Room 212, Bethesda, MD 20892-4340, USA
  • ,
  • M.R Emmert-Buck

      Affiliations

    • Pathogenetics Unit, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
  • ,
  • R.L Strausberg

      Affiliations

    • Cancer Genome Office, Building 3 Room 11A03, Bethesda, MD 20892, USA
  • ,
  • D.B Krizman

      Affiliations

    • Pathogenetics Unit, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
  • ,
  • J.S Gutkind

      Affiliations

    • Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, 30 Convent Drive, Building 30, Room 212, Bethesda, MD 20892-4340, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-301-496-6259; fax +1-301-402-0823

References 

  1. Jen KY, Gewirtz AM. Suppression of gene expression by targeted disruption of messenger RNA (available options and current strategies). Stem Cells. 2000;18:307–319
  2. Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science. 1993;259:946–951
  3. Krizman DB, Wagner L, Lash A, Strausberg RL, Emmert-Buck MR. The Cancer Genome Anatomy Project (EST sequencing and the genetics of cancer progression). Neoplasia. 1999;1:101–106
  4. Peterson LA, Brown MR, Carlisle AJ, Kohn EC, Liotta LA, Emmert-Buck MR, et al.  An improved method for construction of directionally cloned cDNA libraries from microdissected cells. Cancer Res. 1998;58:5326–5328
  5. Krizman DB, Chuaqui RF, Meltzer PS, Trent JM, Duray PH, Linehan WM, et al.  Construction of a representative cDNA library from prostatic intraepithelial neoplasia. Cancer Res. 1996;56:5380–5383
  6. Strausberg RL, Buetow KH, Emmert-Buck MR, Klausner RD. The cancer genome anatomy project (building an annotated gene index). Trends Genet. 2000;16:103–106
  7. Strausberg RL, Dahl CA, Klausner RD. New opportunities for uncovering the molecular basis of cancer. Nat Genet. 1997;15(Spec No):415–416
  8. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8–31,1
  9. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33–64,2
  10. Shillitoe EJ, May M, Patel V, Leethanakul C, Ensley JF, Strausberg RL, et al.  Genome-wide analysis of oral cancer–early results from the Cancer Genome Anatomy Project. Oral Oncol. 2000;36:8–16
  11. Leethanakul C, Patel V, Gillespie J, Shillitoe E, Kellman RM, Ensley JF, et al.  Gene expression profiles in squamous cell carcinomas of the oral cavity: use of laser capture microdissection for the construction and analysis of stage-specific cDNA libraries. Oral Oncol. 2000;36:474–483
  12. Simone NL, Bonner RF, Gillespie JW, Emmert-Buck MR, Liotta LA. Laser-capture microdissection (opening the microscopic frontier to molecular analysis). Trends Genet. 1998;14:272–276
  13. Bonalume NR. Brazilian scientists team up for cancer genome project. Nature. 1999;398:450
  14. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 2 (chromosomal aberrations). Oral Oncol. 2000;36:311–327
  15. Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G, et al.  Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res. 1997;57:759–764
  16. Chan K, Kan YW. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci USA. 1999;96:12731–12736
  17. Wang X, Pavelic ZP, Li Y, Gleich L, Gartside PS, Pavelic L, et al.  Overexpression and amplification of glutathione S-transferase pi gene in head and neck squamous cell carcinomas. Clin Cancer Res. 1997;3:111–114
  18. Shiga H, Heath EI, Rasmussen AA, Trock B, Johnston PG, Forastiere AA, et al.  Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin Cancer Res. 1999;5:4097–4104
  19. Mattijssen V, Peters HM, Schalkwijk L, Manni JJ, van ’t Hof-Grootenboer B, de Mulder PH, et al.  E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer. 1993;55:580–585
  20. Bagutti C, Speight PM, Watt FM. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol. 1998;186:8–16
  21. Tungekar MF, Turley H, Dunnill MS, Gatter KC, Ritter MA, Harris AL. Interleukin 4 receptor expression on human lung tumors and normal lung. Cancer Res. 1991;51:261–264
  22. Mann EA, Spiro JD, Chen LL, Kreutzer DL. Cytokine expression by head and neck squamous cell carcinomas. Am J Surg. 1992;164:567–573
  23. Myers JN, Yasumura S, Suminami Y, Hirabayashi H, Lin W, Johnson JT, et al.  Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukun 4. Clin Cancer Res. 1996;2:127–135
  24. Pi-Sunyer FX. Overnutrition and undernutrition as modifiers of metabolic processes in disease states. Am J Clin Nutr. 2000;72:533S–537S
  25. Tsuchiya T, Shimizu H, Horie T, Mori M. Expression of leptin receptor in lung (leptin as a growth factor). Eur J Pharmacol. 1999;365:273–279

PII: S1368-8375(02)00107-0

doi: 10.1016/S1368-8375(02)00107-0

Oral Oncology
Volume 39, Issue 3 , Pages 248-258 , April 2003